Cargando…
Antibody responses after two doses of CoronaVac of the participants with or without the diagnosis of COVID-19
BACKGROUND: CoronaVac, an inactivated whole-virion vaccine against COVID-19, has been shown to be safe with acceptable antibody responses by various clinical trials. AIMS: The objective was to investigate the post-vaccination antibody levels of both symptomatic and asymptomatic healthcare workers wi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743087/ https://www.ncbi.nlm.nih.gov/pubmed/35001336 http://dx.doi.org/10.1007/s11845-021-02883-x |